RENALYTIX PLC LS-0025 (2O9) - Cash Flow Conversion Efficiency

Latest as of December 2024: 4.746x

Based on the latest financial reports, RENALYTIX PLC LS-0025 (2O9) has a cash flow conversion efficiency ratio of 4.746x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-6.50 Million ≈ $-7.60 Million USD) by net assets (€-1.37 Million ≈ $-1.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see RENALYTIX PLC LS-0025 (2O9) market capitalisation for the company's overall valuation and market capitalisation.

RENALYTIX PLC LS-0025 - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how RENALYTIX PLC LS-0025's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of RENALYTIX PLC LS-0025 for real-time trading data and today's change.

RENALYTIX PLC LS-0025 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RENALYTIX PLC LS-0025 ranked by their cash flow conversion efficiency. Review RENALYTIX PLC LS-0025 (2O9) flexibility index to assess the company's free cash flow relative to its total liabilities.

Company	Cash Flow Conversion Efficiency
MBL Infrastructure Limited NSE:MBLINFRA	0.003x
Staatl. Mineralbrunnen AG MU:SLB	N/A
Touchstone Exploration Inc TO:TXP	0.068x
Able View Global Inc. Class B Ordinary Shares NASDAQ:ABLV	-0.121x
Mangalam Organics Limited NSE:MANORG	0.034x
Bonia Corporation Bhd KLSE:9288	0.041x
Sangsangin Industry Co. Ltd. KQ:101000	-0.035x
PGF Polska Grupa Fotowoltaiczna SA WAR:PGV	0.000x

Annual Cash Flow Conversion Efficiency for RENALYTIX PLC LS-0025 (2022–2025)

The table below shows the annual cash flow conversion efficiency of RENALYTIX PLC LS-0025 from 2022 to 2025. Also see total assets of RENALYTIX PLC LS-0025 for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	€-7.00 Million ≈ $-8.18 Million	€-17.90 Million ≈ $-20.93 Million	2.557x	-22.77%
2024-06-30	€-9.00 Million ≈ $-10.52 Million	€-29.80 Million ≈ $-34.84 Million	3.311x	+167.68%
2023-06-30	€6.97 Million ≈ $8.15 Million	€-34.09 Million ≈ $-39.85 Million	-4.892x	-226.06%
2022-06-30	€30.61 Million ≈ $35.78 Million	€-45.92 Million ≈ $-53.69 Million	-1.500x	--

About RENALYTIX PLC LS-0025

F:2O9 Germany Health Information Services

Market Cap

$46.64 Million

€39.89 Million EUR

Market Cap Rank

#22781 Global

#1995 in Germany

Share Price

€0.06

Change (1 day)

-7.75%

52-Week Range

€0.01 - €0.10

All Time High

€13.60